Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Bridge Pharma (United States)
InstitutionResearch output, impact & collaborations
Bridge Pharma (United States) is a research organisation in Sarasota, US. OpenAlex records 1,267 works and 35,276 citations for it. 608 researchers list it as their most recent affiliation.
1,267
Works
35,276
Citations
608
Researchers
33
Avg h-index
How has Bridge Pharma (United States)'s publication output changed over time?
ScholarIQpublication output · 2008–2023
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2023.
1
1
1
1
2
2
1
1
20082011201220192020202120222023
Who are the most-cited researchers behind Bridge Pharma (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Bridge Pharma (United States)?
ScholarIQmost cited works
The relationship between cognition and functioning in schizophrenia: A semi-systematic review
Saifuddin Kharawala, Claudia Hastedt, Jana Podhorná, Hemlata Shukla, Bregt S Kappelhoff, Philip D. Harvey
S2898356475. 2021138 CitationsOPEN ACCESS
The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review
Saifuddin Kharawala, Amanda Golembesky, Rhonda L. Bohn, Dirk Eßer
Expert Review of Clinical Immunology. 2020102 CitationsOPEN ACCESS
Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations
Jagadisha Thirthalli, Balaji Bharadwaj, Sandip Kulkarni, Saifuddin Kharawala, Chittaranjan Andrade, Bangalore N. Gangadhar
Schizophrenia Research. 200838 Citations
A systematic review of seizure clusters: Prevalence, risk factors, burden of disease and treatment patterns
Steve Chung, Jerzy P. Szaflarski, Eun Jung Choi, Jessica C. Wilson, Saifuddin Kharawala, Gavneet Kaur, Lawrence J. Hirsch
S144140688. 202135 Citations
Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations
Umesh Gupta, Saifuddin Kharawala
S2738047733. 201230 CitationsOPEN ACCESS
How much of the research on Bridge Pharma (United States) is open access?
ScholarIQopen access share
80%OPEN ACCESS
Gold
50%
Green
0%
Hybrid
30%
Bronze
0%
Closed
20%
Related on ScholarIQ
Amyloidosis: Diagnosis, Treatment, Outcomes
Top Topic
Parathyroid Disorders and Treatments
Top Topic
Structural Engineering and Vibration Analysis
Top Topic
Structural Load-Bearing Analysis
Top Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Top Topic
Geotechnical Engineering and Underground Structures
Top Topic